Stent price caps chasing manufacturers from the market
Global pharmaceutical companies are trying to withdraw from the Indian coronary stent market following a price cap introduced by the National Pharmaceutical Pricing Authority (NPPA). The price cap of stents has proven an unpopular move amongst international investors and pharmaceutical manufacturers. Some international pharmaceutical companies, such as Abbott and Medtronic have already submitted withdrawal requests …
Stent price caps chasing manufacturers from the market Read More »